Monoclonal antibody offers sturdy real-world safety in opposition to extreme RSV in infants, suggests meta-analysis
Credit score: Pixabay/CC0 Public Area Nirsevimab, a monoclonal antibody, is extremely efficient in real-world situations at stopping extreme respiratory syncytial...